Exact Mass: 475.3046
Exact Mass Matches: 475.3046
Found 500 metabolites which its exact mass value is equals to given mass value 475.3046
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Netilmicin
Netilmicin is a semisynthetic 1-N-ethyl derivative of sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. [PubChem] Netilmicin inhibits protein synthesis in susceptible organisms by binding to the bacterial 30S ribosomal subunit and interfering with mRNA binding and the acceptor tRNA site. The bactericidal effect of netilmiicin is not fully understood. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic
Marckine
Alangimarckine
A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 as well as a hydroxy group at position 9.
Ulipristal acetate
A 20-oxo steroid obtained by acetylation of the 17-hydroxy group of (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-ol (ulipristal). A selective progesterone receptor modulator, which is employed as an emergency contraceptive. C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
LysoPE(0:0/18:3(9Z,12Z,15Z))
LysoPE(0:0/18:3(9Z,12Z,15Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/18:3(9Z,12Z,15Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/18:3(6Z,9Z,12Z))
LysoPE(0:0/18:3(6Z,9Z,12Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/18:3(6Z,9Z,12Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(18:3(6Z,9Z,12Z)/0:0)
LysoPE(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Hydrocortamate
Hydrocortamate is a synthetic glucocorticoid used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
LysoPE(18:3(9Z,12Z,15Z)/0:0)
LysoPE(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
N-Docosahexaenoyl phenylalanine
N-docosahexaenoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl phenylalanine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Z-Leu-leu-leu-al
Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate
Ulipristal acetate
Z-LLNle-CHO
Glu Val Thr Lys
Thr Val Lys Glu
C27H41NO6_(7E)-11-Hydroxy-3-isobutyl-4,5,8,13,13-pentamethyl-3,3a,4,6a,9,10,11,11a,14a,15-decahydro-1H-[1,3]dioxolo[9,10]oxacyclododecino[2,3-d]isoindole-1,16(2H)-dione
Ala Met Arg Val
Ala Met Val Arg
Ala Arg Met Val
Ala Arg Val Met
Ala Val Met Arg
Ala Val Arg Met
Cys Ile Ile Lys
Cys Ile Lys Ile
Cys Ile Lys Leu
Cys Ile Leu Lys
Cys Lys Ile Ile
Cys Lys Ile Leu
Cys Lys Leu Ile
Cys Lys Leu Leu
Cys Leu Ile Lys
Cys Leu Lys Ile
Cys Leu Lys Leu
Cys Leu Leu Lys
Cys Arg Val Val
Cys Val Arg Val
Cys Val Val Arg
Asp Ile Lys Thr
Asp Ile Thr Lys
Asp Lys Ile Thr
Asp Lys Leu Thr
Asp Lys Thr Ile
Asp Lys Thr Leu
Asp Leu Lys Thr
Asp Leu Thr Lys
Asp Thr Ile Lys
Asp Thr Lys Ile
Asp Thr Lys Leu
Asp Thr Leu Lys
Glu Ile Lys Ser
Glu Ile Ser Lys
Glu Lys Ile Ser
Glu Lys Leu Ser
Glu Lys Ser Ile
Glu Lys Ser Leu
Glu Lys Thr Val
Glu Lys Val Thr
Glu Leu Lys Ser
Glu Leu Ser Lys
Glu Ser Ile Lys
Glu Ser Lys Ile
Glu Ser Lys Leu
Glu Ser Leu Lys
Glu Thr Lys Val
Glu Thr Val Lys
Glu Val Lys Thr
Gly Ile Met Arg
Gly Ile Arg Met
Gly Leu Met Arg
Gly Leu Arg Met
Gly Met Ile Arg
Gly Met Leu Arg
Gly Met Arg Ile
Gly Met Arg Leu
Gly Arg Ile Met
Gly Arg Leu Met
Gly Arg Met Ile
Gly Arg Met Leu
Ile Cys Ile Lys
Ile Cys Lys Ile
Ile Cys Lys Leu
Ile Cys Leu Lys
Ile Asp Lys Thr
Ile Asp Thr Lys
Ile Glu Lys Ser
Ile Glu Ser Lys
Ile Gly Met Arg
Ile Gly Arg Met
Ile Ile Cys Lys
Ile Ile Lys Cys
Ile Lys Cys Ile
Ile Lys Cys Leu
Ile Lys Asp Thr
Ile Lys Glu Ser
Ile Lys Ile Cys
Ile Lys Leu Cys
Ile Lys Ser Glu
Ile Lys Thr Asp
Ile Leu Cys Lys
Ile Leu Lys Cys
Ile Met Gly Arg
Ile Met Arg Gly
Ile Arg Gly Met
Ile Arg Met Gly
Ile Arg Ser Thr
Ile Arg Thr Ser
Ile Ser Glu Lys
Ile Ser Lys Glu
Ile Ser Arg Thr
Ile Ser Thr Arg
Ile Thr Asp Lys
Ile Thr Lys Asp
Ile Thr Arg Ser
Ile Thr Ser Arg
Lys Cys Ile Ile
Lys Cys Ile Leu
Lys Cys Leu Ile
Lys Cys Leu Leu
Lys Asp Ile Thr
Lys Asp Leu Thr
Lys Asp Thr Ile
Lys Asp Thr Leu
Lys Glu Ile Ser
Lys Glu Leu Ser
Lys Glu Ser Ile
Lys Glu Ser Leu
Lys Glu Thr Val
Lys Glu Val Thr
Lys Ile Cys Ile
Lys Ile Cys Leu
Lys Ile Asp Thr
Lys Ile Glu Ser
Lys Ile Ile Cys
Lys Ile Leu Cys
Lys Ile Ser Glu
Lys Ile Thr Asp
Lys Lys Asn Ser
Lys Lys Ser Asn
Lys Leu Cys Ile
Lys Leu Cys Leu
Lys Leu Asp Thr
Lys Leu Glu Ser
Lys Leu Ile Cys
Lys Leu Leu Cys
Lys Leu Ser Glu
Lys Leu Thr Asp
Lys Met Val Val
Lys Asn Lys Ser
Lys Asn Ser Lys
Lys Ser Glu Ile
Lys Ser Glu Leu
Lys Ser Ile Glu
Lys Ser Lys Asn
Lys Ser Leu Glu
Lys Ser Asn Lys
Lys Thr Asp Ile
Lys Thr Asp Leu
Lys Thr Glu Val
Lys Thr Ile Asp
Lys Thr Leu Asp
Lys Thr Val Glu
Lys Val Glu Thr
Lys Val Met Val
Lys Val Thr Glu
Lys Val Val Met
Leu Cys Ile Lys
Leu Cys Lys Ile
Leu Cys Lys Leu
Leu Cys Leu Lys
Leu Asp Lys Thr
Leu Asp Thr Lys
Leu Glu Lys Ser
Leu Glu Ser Lys
Leu Gly Met Arg
Leu Gly Arg Met
Leu Ile Cys Lys
Leu Ile Lys Cys
Leu Lys Cys Ile
Leu Lys Cys Leu
Leu Lys Asp Thr
Leu Lys Glu Ser
Leu Lys Ile Cys
Leu Lys Leu Cys
Leu Lys Ser Glu
Leu Lys Thr Asp
Leu Leu Cys Lys
Leu Leu Lys Cys
Leu Met Gly Arg
Leu Met Arg Gly
Leu Arg Gly Met
Leu Arg Met Gly
Leu Arg Ser Thr
Leu Arg Thr Ser
Leu Ser Glu Lys
Leu Ser Lys Glu
Leu Ser Arg Thr
Leu Ser Thr Arg
Leu Thr Asp Lys
Leu Thr Lys Asp
Leu Thr Arg Ser
Leu Thr Ser Arg
Met Ala Arg Val
Met Ala Val Arg
Met Gly Ile Arg
Met Gly Leu Arg
Met Gly Arg Ile
Met Gly Arg Leu
Met Ile Gly Arg
Met Ile Arg Gly
Met Lys Val Val
Met Leu Gly Arg
Met Leu Arg Gly
Met Arg Ala Val
Met Arg Gly Ile
Met Arg Gly Leu
Met Arg Ile Gly
Met Arg Leu Gly
Met Arg Val Ala
Met Val Ala Arg
Met Val Lys Val
Met Val Arg Ala
Met Val Val Lys
Asn Lys Lys Ser
Asn Lys Ser Lys
Asn Ser Lys Lys
Arg Ala Met Val
Arg Ala Val Met
Arg Cys Val Val
Arg Gly Ile Met
Arg Gly Leu Met
Arg Gly Met Ile
Arg Gly Met Leu
Arg Ile Gly Met
Arg Ile Met Gly
Arg Ile Ser Thr
Arg Ile Thr Ser
Arg Leu Gly Met
Arg Leu Met Gly
Arg Leu Ser Thr
Arg Leu Thr Ser
Arg Met Ala Val
Arg Met Gly Ile
Arg Met Gly Leu
Arg Met Ile Gly
Arg Met Leu Gly
Arg Met Val Ala
Arg Ser Ile Thr
Arg Ser Leu Thr
Arg Ser Thr Ile
Arg Ser Thr Leu
Arg Thr Ile Ser
Arg Thr Leu Ser
Arg Thr Ser Ile
Arg Thr Ser Leu
Arg Thr Thr Val
Arg Thr Val Thr
Arg Val Ala Met
Arg Val Cys Val
Arg Val Met Ala
Arg Val Thr Thr
Arg Val Val Cys
Ser Glu Ile Lys
Ser Glu Lys Ile
Ser Glu Lys Leu
Ser Glu Leu Lys
Ser Ile Glu Lys
Ser Ile Lys Glu
Ser Ile Arg Thr
Ser Ile Thr Arg
Ser Lys Glu Ile
Ser Lys Glu Leu
Ser Lys Ile Glu
Ser Lys Lys Asn
Ser Lys Leu Glu
Ser Lys Asn Lys
Ser Leu Glu Lys
Ser Leu Lys Glu
Ser Leu Arg Thr
Ser Leu Thr Arg
Ser Asn Lys Lys
Ser Arg Ile Thr
Ser Arg Leu Thr
Ser Arg Thr Ile
Ser Arg Thr Leu
Ser Thr Ile Arg
Ser Thr Leu Arg
Ser Thr Arg Ile
Ser Thr Arg Leu
Thr Asp Ile Lys
Thr Asp Lys Ile
Thr Asp Lys Leu
Thr Asp Leu Lys
Thr Glu Lys Val
Thr Glu Val Lys
Thr Ile Asp Lys
Thr Ile Lys Asp
Thr Ile Arg Ser
Thr Ile Ser Arg
Thr Lys Asp Ile
Thr Lys Asp Leu
Thr Lys Glu Val
Thr Lys Ile Asp
Thr Lys Leu Asp
Thr Lys Val Glu
Thr Leu Asp Lys
Thr Leu Lys Asp
Thr Leu Arg Ser
Thr Leu Ser Arg
Thr Arg Ile Ser
Thr Arg Leu Ser
Thr Arg Ser Ile
Thr Arg Ser Leu
Thr Arg Thr Val
Thr Arg Val Thr
Thr Ser Ile Arg
Thr Ser Leu Arg
Thr Ser Arg Ile
Thr Ser Arg Leu
Thr Thr Arg Val
Thr Thr Val Arg
Thr Val Glu Lys
Thr Val Arg Thr
Thr Val Thr Arg
Val Ala Met Arg
Val Ala Arg Met
Val Cys Arg Val
Val Cys Val Arg
Val Glu Lys Thr
Val Glu Thr Lys
Val Lys Glu Thr
Val Lys Met Val
Val Lys Thr Glu
Val Lys Val Met
Val Met Ala Arg
Val Met Lys Val
Val Met Arg Ala
Val Met Val Lys
Val Arg Thr Thr
Val Thr Glu Lys
Val Thr Lys Glu
Val Thr Arg Thr
Val Thr Thr Arg
Val Val Lys Met
Val Val Met Lys
MG-132
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
LysoPE(18:3/0:0)
hydrocortamate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
1-[[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]-propan-2-ylamino]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester
3-Pyridinemethanol, 4-[4-fluoro-2-(phenylmethoxy)phenyl]-a-methyl-2,6-bis(1-methylethyl)-5-(1-penten-1-yl)-
1-HYDROXY-N-[4-(2,4-DI-TERT-PENTYLPHENOXY)BUTYL]-2-NAPHTHAMIDE
Z-Leu-Leu-Nle-aldehyde
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators Z-LLNle-CHO (Z-Leu-Leu-Nle-CHO) is a γ-secretase inhibitor I. Z-LLNle-CHO induces caspase and ROS-dependent apoptosis by blocking the Akt-mediated pro-survival pathway. Z-LLNle-CHO can be used in cancer research, such as breast cancer and leukaemia[1][2].
2(3H)-Furanone, 5-hexyldihydro-4-methyl-, mixt. with 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride (1:1)
1-HYDROXY-N-(2-TETRADECYLOXYPHENYL)-2-NAPHTHALENECARBOXAMIDE
Propanamide, N-(2,6-dimethyl-4-((4-(methyl(2-phenylethyl)amino)-1-piperidinyl)carbonyl)phenyl)-, hydrochloride, hydrate (1:1:1)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] octadeca-6,9,12-trienoate
1-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine
(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate
1-(N-[2-(benzotriazol-1-yl)acetyl]-4-methoxyanilino)-N-cyclopentylcyclohexane-1-carboxamide
[(8S,11R,13S,14S,17S)-17-Acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
N-[4-methyl-1-[[4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamic acid (phenylmethyl) ester
N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
(8R,9R,10R)-10-(hydroxymethyl)-N-(4-methoxyphenyl)-9-[4-(4-methylpent-1-ynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(3-morpholin-4-ylpropyl)acetamide
2-[(3S,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(3R,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
2-[(3R,6aR,8R,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
2-[(3S,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(3S,6aS,8S,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-amino-2-methoxypropane-1,3-diol;(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]dec-4-ene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] acetate
(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)dodeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]dodec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]undec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecane-1-sulfonic acid
(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decane-1-sulfonic acid
(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-ene-1-sulfonic acid
(E)-2-(decanoylamino)-3-hydroxypentadec-4-ene-1-sulfonic acid
(E)-2-(dodecanoylamino)-3-hydroxytridec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecane-1-sulfonic acid
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Tubulosine
A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 and a hydroxy group at the 8 position.
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine
(1S,2S,3R,4S,6R)-4-amino-3-[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yloxy]-6-(ethylamino)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside
Benzyl n-[(2s)-4-methyl-1-[[(2r)-4-methyl-1-[[(2s)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate
N-hexanoylsphingosine 1-phosphate(2-)
A ceramide 1-phosphate(2-) in which the ceramide N-acyl group is specified as hexanoyl; major species at pH 7.3.
PE(18:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved